Table 3.
Univariate | Multivariateb | ||||
---|---|---|---|---|---|
Characteristic | OR (95% CI) | p-value | aOR (95% CI)b | p-value | |
Maternal characteristics | |||||
Age (years) | 0.95 (0.89–1.02) | 0.137 | |||
Unmarried/not cohabiting | 1.56 (0.33–7.41) | 0.572 | |||
Duration of relationship (years) | 0.91 (0.84–0.98) | 0.017* | 0.90 (0.82–0.98) | 0.015* | |
Education | None | ref | |||
Primary | 1.31 (0.40–4.30) | 0.653 | |||
Secondary | 1.63 (0.46–5.78) | 0.447 | |||
> Secondary | 1.67 (1.41–6.74) | 0.470 | |||
Employment | Salaried | ref | ref | ||
Self employed | 4.18 (0.49–35.51) | 0.188 | 4.11 (0.47–35.77) | 0.198 | |
Housewife | 5.67 (0.71–45.23) | 0.100 | 5.07 (0.65–39.52) | 0.120 | |
Unemployed | 10.47 (1.20–91.31) | 0.034* | 9.19 (1.06–79.41) | 0.044 | |
KSH ≤ 5000 income/month | 0.61 (0.26–1.47) | 0.269 | |||
IPV (from current male partner)c | 1.08 (0.49–2.38) | 0.853 | |||
Current male partner characteristics | |||||
Partner age (years) | 0.97 (0.92–1.02) | 0.209 | |||
Partner education | None | ref | |||
Primary | 0.29 (0.08–1.03) | 0.056 | |||
Secondary | 0.40 (0.11–1.45) | 0.163 | |||
> Secondary | 0.44 (0.10–2.03) | 0.290 | |||
Partner employment | Unemployed | ref | ref | ||
Self employed | 0.59 (0.28–1.25) | 0.165 | 0.61 (0.30–1.24) | 0.169 | |
Salaried | 0.43 (0.20–0.93) | 0.033* | 0.42 (0.18–0.96) | 0.039 | |
Partner tested for HIV | 0.69 (0.26–1.81) | 0.445 | |||
Partner HIV statusd | HIV-uninfected | ref | |||
HIV-infected | 0.46 (0.17–1.24) | 0.124 | |||
Unknown | – | ||||
Obstetric history | |||||
Number of living children | 0.89 (0.69–1.16) | 0.405 | |||
≥4 ANC visitse | 0.65 (0.37–1.15) | 0.139 | |||
Partner did not attend ANCe | 2.65 (1.29–5.43) | 0.009* | 2.62 (1.28–5.35) | 0.009* | |
Health facility deliverye | 1.10 (0.48–2.54) | 0.823 | |||
HIV-related characteristics | |||||
CD4 testing uptake | 0.29 (0.14–0.59) | 0.001* | 0.32 (0.15–0.69) | 0.004 | |
CD4 results received | 0.49 (0.22–1.10) | 0.084 | |||
Currently on HAART for own health | 0.39 (0.21–0.74) | 0.005* | 0.51 (0.25–1.04) | 0.063 | |
Maternal ARV use | |||||
During pregnancy | 0.42 (0.16–1.10) | 0.078 | |||
During labour | 0.25 (0.11–0.53) | < 0.001* | 0.38 (0.15–0.97) | 0.042 | |
During breastfeeding | 0.30 (0.15–0.62) | < 0.001* | 0.50 (0.22–1.14) | 0.096 | |
Infant received PCR testing | 0.56 (0.31–1.01) | 0.053* | 0.60 (0.32–1.09) | 0.093 | |
Infant ARV use | 0.08 (0.03–0.22) | < 0.001* | 0.08 (0.02–0.31) | < 0.001 |
SD standard deviation, IPV intimate partner violence, ANC antenatal care, OR odds ratio, aOR adjusted odds ratio
aMissing data not shown; all models adjusted for clinic-level clustering
bMultivariate models adjusted for marital status, relationship length, and partner ANC attendance
cIPV defined as having a score ≥ 10.5 on HITS scale
dAmong male partners who were tested for HIV
eDuring the most recent pregnancy
*highlights factors were significantly different in univariate analysis